Johnson & Johnson Ordered to Pay $572 Million for Role in Opiate Crisis
In a landmark ruling, Oklahoma judge Thad Balkman ruled against pharmaceutical giant Johnson & Johnson today in the first trial meant to extract retribution from drugmakers for fueling the unprecedented wave of opiate-related overdoses and deaths in the U.S.